@prefix this: <http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs> .
@prefix sub: <http://purl.org/np/RAibbhN7-pBTHpqLrZjZ-kS8gQF0I8rsWpra8jNe0AVjs#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   <http://purl.obolibrary.org/obo/DOID_13884> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_13884> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB00489> ;
    a rdf:Statement ;
    rdfs:label "\"SORINE (sotalol hydrochloride) tablets are contraindicated in patients with:   Sinus bradycardia, sick sinus syndrome, second and third degree AV block, unless a functioning pacemaker is present Congenital or acquired long QT syndromes Cardiogenic shock or decompensated heart failure Serum potassium <4 mEq/L Bronchial asthma or related bronchospastic conditions Hypersensitivity to sotalol For the treatment of AFIB/AFL, SORINE (sotalol hydrochloride) tablets are also contraindicated in patients with:   Baseline QT interval >450 ms Creatinine clearance <40 mL/min For the treatment of AFIB/AFL or ventricular arrhythmias   Sinus bradycardia, 2 nd  rd  4 Congenital or acquired long QT syndrome ( 4 Serum potassium <4 mEq/L( 4 Cardiogenic shock, decompensated heart failure ( 4 Bronchial asthma or related bronchospastic conditions ( 4 Hypersensitivity to sotalol ( 4 For the treatment of AFIB/AFL also contraindicated for:   QT interval >450 ms ( 4 Creatinine clearance <40 mL/min ( 4\"" ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:MedicalContraindication .
  <https://identifiers.org/drugbank:DB00489> bl:category bl:Drug .
}
sub:provenance {
   sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "VSHPKdmtZp4YPGIzA5Vilm3iE46WumMcSAEqbDV9Pen8Q7CHQDPZLPhwuP3jRFizxYx+WOnLVaF/kPls8usdKif2zqEh6YYcJFmdBfFOtvQ4UQyqqKOkWw9Xjvk1HbrrIUSJqNb0AeZcZnut2WEbxXTDYdFSFwbgR6sC4CNcCMA=" ;
    npx:hasSignatureTarget this: .
  this: dct:created "2021-08-23T12:23:16.631+02:00"^^xsd:dateTime ;
    dct:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}